Regulatory Screening

Regulatory Screening

Cross-border M&A is fraught with overlapping regulatory regimes. Failing to file for antitrust clearance or FDI approval in a tertiary jurisdiction can lead to massive fines, mandated divestitures, or forced deal unwinding.

When to Use

• Evaluating a cross-border acquisition for regulatory hurdles
• Initial assessment of antitrust filing requirements across jurisdictions
• FDI screening for foreign acquirers
• Timeline forecasting for regulatory approvals
• Risk allocation planning in definitive agreements

The /screen-fdi Protocol

How It Works

1. Ingest the target's geographic revenue breakdown, physical asset locations, and customer distribution
2. Cross-reference against the latest global thresholds for:
   • Mandatory merger control filings (HSR in US, CMA in UK, EC in EU, SAMR in China, etc.)
   • FDI notification requirements (CFIUS, EU FDI Screening Regulation, etc.)
   • Sector-specific reviews (defense, critical infrastructure, healthcare, telecoms)
3. Flag jurisdictions requiring mandatory pre-close filings
4. Estimate review timelines and potential remedies

Output Format

## Regulatory Screening Report

### Deal Parameters
- **Acquirer jurisdiction**: [Country]
- **Target jurisdictions**: [List]
- **Combined revenue**: $[X]M
- **Sector(s)**: [Industry classification]

### Filing Requirements

| Jurisdiction | Regime | Threshold | Status | Est. Timeline | Risk Level |
|-------------|--------|-----------|--------|---------------|------------|
| United States | HSR Act | Size-of-transaction >$[X]M | FILING REQUIRED | 30-60 days | 🟡 |
| European Union | EC Merger Reg | Combined turnover >€5B | FILING REQUIRED | 25-90 working days | 🟡 |
| United Kingdom | CMA | UK turnover >£70M or >25% share | REVIEW LIKELY | 40-60 working days | 🟡 |
| China | SAMR | [Thresholds] | TO BE ASSESSED | 30-180 days | 🔴 |

### FDI-Specific Risks
| Jurisdiction | Trigger | Required Action |
|-------------|---------|-----------------|
| [Country] | [Critical infrastructure / national security] | Mandatory pre-close notification |

### Structural Recommendations
- [Strategies to avoid/mitigate regulatory triggers]
- [Suggested risk allocation in purchase agreement]

### Timeline Impact
- **Earliest possible close**: [Date estimate]
- **Critical path**: [Longest regulatory review]

⚠️ Explicit Limitation: This tool provides preliminary screening only and does not replace formal antitrust legal counsel. Thresholds change annually. Always verify current filing requirements with qualified competition lawyers.

Operating Guidelines

• This is a preliminary screening tool — always verify with qualified legal counsel
• Thresholds are jurisdiction and year-specific — flag if data may be outdated
• Consider both target-side and acquirer-side revenue for combined thresholds
• Sector-specific reviews (defense, telecoms, critical infrastructure) have lower thresholds
• For Chinese (SAMR) filings, timeline can extend to 180+ days — plan accordingly
• FDI screening is increasingly aggressive globally post-2020 — err on the side of filing
• Include regulatory risk allocation in the SPA (who bears risk of non-approval, break fees)

Time saved: 8+ hours of preliminary legal research per transaction.

Examples

Input: "$450M acquisition of a US target with EU revenues of €320M."

Filing flag output:

Recommended timeline: Flag HSR filing to deal team immediately — 30-day waiting period affects closing timeline.

Troubleshooting